QD Laser Inc of Kanagawa Japan and the Institute for Nano Quantum Information Electronics (NanoQuine) at the University of Tokyo have unveiled the prototype of their retina imaging laser eyewear for low-vision care. The plan is to ...
Tags: QD Laser, NanoQuine, Laser Eyewear
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the Scottish Medicines Consortium (SMC) has accepted ILUVIEN® for use ...
A new gene therapy that successfully treated a rare eye disease in clinical trials could prove the key to preventing more common inherited causes of blindness, researchers say. In six male patients, doctors used a virus to repair a ...
For many suffering from blindness, the perfect Christmas gift has arrived. Next month, the Argus II Retinal Prothesis System by Second Sight is slated to go on sale in the United States. The Argus II by Second Sight can restore sight for ...
Tags: Bionic Eye, blindness
Allegro Ophthalmics has received approval from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to commence two Phase II clinical studies of integrin peptide therapy ALG-1001. The new trials, ...
Tags: Eye Disease Patients
The US Patent and Trademark Office (USPTO) has granted an US patent to the InSite Vision’s DuraSite 2 next-generation enhanced drug delivery system, which will be valid up to 2029 for internal pipeline and partnering. Offering a ...
Tags: Drug Delivery System
InSite Vision has secured the new patent for its DuraSite 2 next-generation enhanced drug delivery system from the United States Patent and Trademark Office (USPTO). DuraSite 2's ability to significantly improve drug retention and ...
Tags: Insite Vision, Ophthalmic Drug
Summer sun increases the risk of age-related macular degeneration, the leading cause of blindness in adults. A number of steps can help prevent that disease, as well as your risk of developing cataracts, diabetic retinopathy, and glaucoma. ...
Tags: Eyes, Summer, Health&Medicine
One likely effect of the growing number of young people with type 2 diabetes is that more and more people in their 20s and 30s are developing serious eye problems not correctable with glasses. "We've all been aware that obesity and ...
Tags: diabetes, eye problems, eye health, eye diseases
Aflac has introduced a new individual vision insurance plan, Vision Now, to help support workers and employers to providing essential vision benefits without adding benefits costs. The new insurance plan will provide enhanced benefits for ...
Tags: Aflac, Enhanced Vision, Insurance Plan
Allergan and Molecular Partners have expanded their existing relationship by entering into two separate agreements to discover, develop and commercialize proprietary therapeutic DARPin products to treat ophthalmic diseases. The first ...